Clinical Trials Browser

Interventional × Patient Compliance × Lapatinib × Clear all

NCT01273610 2025-06-10

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Phase 2 Active not recruiting

40 enrolled 15 charts

Breast Neoplasms, Patient Compliance